Introduction
A decrease in the incidence of respiratory distress syndrome (RDS) in the newborn following maternal glucocorticoid treatment has been documented by LlGGINS and HOWIE [20, 21] , and confirmed by others [5, 8, 23, 29] . Experimental studies have shown that glucocorticoid therapy stimulates the synthesis [1, [25] [26] [27] and secretion [9, 10, 24] of the major surfactant component, disaturated lecithin.
Beta-sympathomimetic drugs are widely used to prevent premature uterine activity. These drugs cross the placenta [30] and may thus affect fetal organs including the lung. Following betasympathomimetic drug administration in premature labor, the incidence of RDS has been reported to increase [7] , to decrease [6] , or to remain unaltered [20] . Beta-sympathomimetic stimulation increases the secretion of surfactant from its intracellular storage in adults [22] and in fetuses [9, 11, 32] . In addition, a beta-sympathomimetic drug decreases the secretion rate of fetal lung fluid [31] . In the present study we have investigated the effect of a glucocorticoid agent and a beta-sympathomimetic drug on the phos- pholipids of the alveolar lavage fluid from premature rabbits in order to evaluate whether both these drugs accelerate fetal lung maturation.
Materials and methods
New Zealand albino rabbits were used. The time of conception was known within ± 4 hours. The protocols for the administration of the drugs are shown in Tab (10) . The pregnant does were operated upon under local anesthesia using 3-4 ml of 0.25% of lidocaine without adrenalin. Betamethasone sodium phosphate (0.12mg) and betamethasone acetate (0.12mg) (Celestone Chronodose®, Schering Corp), ritodrine hydrochloride (0.5 mg) (Utopar®, Ferrosan), or 0.9% saline were given intramuscularly in 0.05 ml to the fetus. Following the drug injections, 0.02-0.03 ml of barium sulfate was injected intramuscularly, in order to identify the drug-exposed fetuses by radiography after the experiment. One to two fetuses received the injection and the littermates served as controls. Th? ( fetuses were removed from the uterus by cesarean section under local anesthesia, and the umbilical cord was cut. The position of the individual fetuses in the uterine horns was identified. The newborn animals were kept in room air at 25 °C, and were allowed to breathe for 5 or 30 minutes (Tab. I). Following the intracerebral injection of 0.1 ml of phenobarbital, the airways were lavaged as described previously [15] . The total lipid fraction was isolated according to BLIGH and DYER [4] . An aliquot was taken for analysis of disaturated phosphatidylcholine [15] . The rest were analyzed by two-dimensional thin-layer chromatography and the individual phospholipids were quantified by measuring their phosphorus contents [15] . For each phospholipid analysis, lavages from three to four fetuses were pooled. The results were expressed as the mean ± SEM, and the statistical significance was calculated using the t-test. 0.241 ±0.010g, p < 0.02). There was no significant difference in the lung dry weight/total body weight ratio as compared between the two groups (0.0065 ± 0.0003, control: 0.0066 ±0.0006). Injection of saline and barium sulfate to the fetus had no effect on the body or lung weights of the fetus (data not shown).
The recovery of the phospholipids in alveolar lavage following betamethasone treatment is shown in Tab. if except the data for phosphatidylglycerol, phosphalidylethanolamine, and bis-(monoacyl· glycerol) phosphate. Betamethasone significantly increased the recovery of total phospholipid, phosphatidylcholine, disaturated phosphatidylcholine and phosphatidylinositol as compared to littermate controls, and increased disaturated phosphatidylcholine and phosphatidylinositol as compared to saline treated controls. The drug had no significant effect on the other phospholipids.
The effect of betamethasone on the phospholipid composition is shown in Tab. III. The drug increased disaturated phosphatidylcholine/sphingomyelin ratio and phosphatidylinositol. In addition, betamethasone decreased phosphatidylserine as compared to littermate controls. Saline injection to the fetus had no significant effect on the quality or quantity of alveolar lavage phospholipids, as compared to the littermatcs (data not shown).
3.2 Effect of beta-sympathomimetic drug treatment: A low dose of ritodrine, injected into the doe, had no effect on either the various phospholipid fractions of the alveolar lavage (Tab. IV), or the recovery of total phospholipid (ritodrine: 5.3 ± 0.8 nmoles/g body weight; saline-control: 5.1 ± 0.6 nmoles/g body weight), or the recovery of individual phospholipids (data not shown).
In another experiment, ritodrine was given directly to the fetus and to the premature newborn at birth. The littermates that received ritodrine at choline and phosphatidylinositol. As shown by birth served as controls (Tab. I: G, H). Ritodrine FELDMAN et al., only phds^hatidylglycerol exceeds administration to the fetus and to the newborn the capacity of phosphatidylinositol to activate significantly decreased the recovery of phosphat-lung phosphocholine cytidyltransferase which preidylinositol (0.42 ± 0.04 nmoles/g body weight; sumably is a rate limiting enzyme in phosphatidyl· control, ritodrine at birth: 0.58 ± 0.04 nmoles/g choline synthesis [12] . In addition, both phosphatbody weight, p < 0.02), but had no significant idylglycerol and phosphatidylinositol promote the effect on the total phospholipid recovery absorption of disaturated phosphatidylcholine (4.9 ± 0.3 nmoles/g body weight; control: from subphase to the surface [17] . This is impor-5.4 ± 0.3 nmoles/g body weight), or on the other tant in terms of surfactant function [2] . Therefore, phospholipids (data not shown). Ritodrine admin-the observed increase in surfactant phosphatidylistration to the fetus decreased phosphatidylinosi-inositol seems to explain further the mechanism tol/sphingomyelin and disaturated phosphatidyl· of glucocorticoids in accelerating the lung maturacholine/sphingomyelin ratios (Tab. V). The drug tion and preventing RPS. did not alter the total body weight or the dry Beta-sympatomimetic drugs may improve neonatal weight of the lung (data not shown). respiratory adaptation by decreasing fetal lung Ritodrine given to the fetus and at birth (group fluid secretion [18, 31] or by promoting the secre-' G) decreased phosphatidylinositol/sphingomyelin tion of lung surfactant [11, 32] . (p < 0.02), and disaturated phosphatidylcholine/ It has been proposed that both glucocorticoids and sphingomyelin ratios (p < 0.05), as compared to sympathomimetic drugs affect lung maturation by the offspring of the saline treated does (group F). a mechanism, that increases intracellular cyclic The lavage phospholipids in the newborns that AMP [3] . However, it is unlikely that the glucowere treated with ritodrine at birth (group H) were corticoid effect is solely based upon interaction not significantly different from phospholipids in with cyclic AMP system [14] . the offspring of the saline treated does (group F).
We found that ritodrine did not increase surfactant, when given at birth. Since beta-sympatomimetic drugs acutely increase surfactant secretion in the rabbit fetus of comparable gestational age [1 1 , 30] 4 Discussion it ^ ukel ^ &β Jack of e£fect at birth was due In the present study it was demonstrated that to high endogenous adrenergic activity. On the betamethasone administration to the immature other hand the failure of maternal ritodrine to fetus increases both surfactant phosphatidyl-affect fetal surfactant phospholipids may be solely due to the low dose of the drug. The decrease in disaturated phosphatidylcholine/sphingomyelin ratio and phosphatidylinositol following the high dose of ritodrine (Tab. V) can be due to premature release of surfactant to fetal lung fluid without a compensatory increase in surfactant synthesis [14, 16] , or due to beta-sympathomimetic-induced hyperinsulinemia and hyperglycemia [28] .
The present and previous results demonstrate that, depending on the dosage and time of administration, beta-adrenergic drugs may increase, decrease, or have little effect on the surfactant secretion. This helps to explain the controversy concerning the influence of the sympathomimetic drugs on the incidence of RDS [6, 7, 20] . Since labor may be associated with acceleration of lung maturation [13] , and beta-sympathomimetics delay the premature delivery in some cases, the present data does not contradict the use of small to moderate doses of beta-adrenergic drugs in threatened premature labor.
Summary
Beta-sympathomimetic drugs and glucocorticoid agents are given in preterm labor to prevent severe consequences of prematurity. It is unclear whether beta-sympathomimetics accelerate lung maturation, or whether they only tend to delay preterm delivery. We have evaluated the effects of betamethasone and ritodrine in rabbits on alveolar lavage phospholipids in premature rabbits, a mean of 28.7 days from conception. Betamethasone given to 26-day-old fetuses increased the surfactant phospholipids, phosphatidylinositol and disaturated phosphatidylcholine; increased disaturated phosphatidylcholine/sphingomyelin ratio, and phosphatidylinositol (percent of phospholipids), as compared to untreated littermates, or to saline treated controls. A low dose of ritodrine given to the pregnant doe, and a high dose given at premature birth had no detectable effects on alveolar lavage phospholipids. However, a high dose of ritodrine given one day before the delivery to the fetus and at premature birth decreased the disaturated phosphatidylcholine/sphingomyelin ratio and phosphatidylinositol in alveolar lavage. While glucocorticoid administration increases the synthesis and secretion of surfactant phospholipids, a high dose of a betasympathomimetic drug may decrease the surfactant. However, spontaneous premature labor is associated with accelerated lung maturation, and accordingly the present results do not contradict the use of a low dosage of betasympathomimetic drug to delay preterm delivery.
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Resume
Effets de la betamethasone et de la ritodrine sur la secretion du surfactant pulmonaire chez la foetus On utilise les betamimetiques et les glucocorticoi'des au cours de l'accouchement premature pour eviter les consequences severes de la prematurite. On ne sait pas precisement si les betamimetiques accelerent la maturation pulmonaire, ou si ils retardent seulement le terme de l'accouchement premature. Nous avons determine les effets de la betamethasone et de la ritodrine sur les phospholipides alveolaires receuillis par lavage chez les lapins prematures,nes en moyenne 28,7 jours apres la conception. La betamethasone, donnee aux foetus de 26 jours augmente les phospholipides du surfactant, Phosphatidylinositol et phosphatidylcholine disature; le rapport phosphatidylcholine disature sur sphingomyeline et le phosphatidyl Inositol (% de phospholipides) sont augmentes par rapport aux autres membres de la portee non traites ou aux temoins traites par du serum sale. Une faible dose de ritodrine administree ä la lapine ou une forte dose administree lors de l'accouchement premature n'a pas d'effet detectable sur les phospholipides alveolaires obtenus par lavage. Toutefois. une dose elevee de ritodrine, administree au foetus un jour avant la naissance et lors de l'accouchement premature, diminue le rapport phosphatidylcholine disature sur sphingomyeline et le Phosphatidylinositol du liquide de lavage alveolaire. Alors que les glucocortico'ides augmentent la synthese et la secretion des phospholipides du surfactant, une dose elevee de betamimetique peut diminuer le surfactant. Neanmoins, l'accouchement premature spontane s'accompagne d'uue acceleration de la maturation pulmonaire et en outre, nos resultats ne contre-indiquent pas l'utilisation des betamimetiques ä doses faibles dans le but de retarder l'accouchement premature.
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